Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04447625Phase 2Completed
Phase 2, randomised, open-label trial of ciprofloxacin in endometritis (2 arms), sponsored by Genesis Athens Clinic. Primary endpoints: Treatment efficiency rate and Side-effects rate at 30 days. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04447625.